BioMedical Technology Solutions Holdings, Inc. (“BMTS”) announced yesterday the signing of a Letter of Intent (LOI) with a new international distributor, JATA Technology Solutions Ltd. The targeted performance goal is the sale of 250 to 500 Demolizer® II units throughout the calendar year 2011.
The value of the contract, at standard pricing, will represent revenues of more than $2 million for BMTS. This more than doubles the number of orders in 2010. The distributor intends for distribution to focus initially on the largest country in Africa, where insufficient biomedical waste management has reached epic proportions and demand is strong for a solution.
Africa is in the midst of a concerted effort to curtail improper disposal of biomedical waste. Incineration is one of the few options for sharps destruction in Africa with most incinerators poorly maintained and, in numerous cases, not operational. Therefore, biomedical waste is often burned openly, causing hazardous conditions, or simply dumped leaving people vulnerable to the dangers of untreated sharps waste that can spread disease from needlestick injuries.
The Demolizer® II offers a quality solution to this ever-growing problem. Sharps are treated and destroyed at the clinic using a safe, non-incineration technology. The treated waste is safe for final disposal or recycling. Through adoption of this important technology, clinics can take responsibility for proper waste treatment and prevent the unnecessary spread of disease.
“We are extremely excited about this Letter of Intent as it is the international breakthrough that we have been working towards for our company and shareholders,” stated Don Cox, CEO of BioMedical Technology Solutions. “Our team has been working diligently to secure contracts for 2011 and we believe that this is just the start of a significant market penetration as awareness about the benefits of the Demolizer® II continues to spread both domestically and internationally. With the execution of this LOI, not including new and recurring orders that we are anticipating, BMTS will have the best revenue-generating year in its history and will help us achieve a fair market valuation.”
Tom Von Bank, National Sales Director of BMTS, commented, “Proper biomedical waste disposal is a growing concern globally and a focus of African nations to institute change for the safety of their people and environment. This order is large, but still only represents a small portion of our new client’s distribution base. The potential is vast in this multi-billion dollar industry and we will continue to work closely with our new partner to expand distribution throughout Africa and other countries.”
Headquartered in Englewood, Colorado, BioMedical Technology Solutions Holdings, Inc. sells the Demolizer® II via their wholly owned subsidiary BioMedical Technology Solutions, Inc. Their patented Demolizer® Technology converts infectious biomedical waste into non-infectious material. The Company’s products provide biomedical waste treatment solutions for the more than 1,000,000 low to medium volume medical waste generators in the United States and a worldwide market five times larger than the U.S.
For more information visit: www.bmtscorp.com
Let us hear your thoughts below:
